The association of silent coronary artery disease and metabolic syndrome in Chinese with type 2 diabetes mellitus
- PMID: 17491661
- PMCID: PMC1783535
- DOI: 10.1900/RDS.2004.1.18
The association of silent coronary artery disease and metabolic syndrome in Chinese with type 2 diabetes mellitus
Abstract
Objectives: Cardiovascular diseases account for approximately 75% of the deaths that occur in patients with diabetes. Because the clinical signs of coronary artery disease (CAD) in diabetic patients are hard to detect and routine screening is costly, it would be of great benefit to try to either prevent CAD from occurring or to detect it early and provide optimal care. Therefore, we analyzed the risk factors that might predict CAD in type 2 diabetes mellitus (T2DM) patients with no classical cardiac ischemic symptoms.
Methods: Using a resting 12-lead ECG, exercise treadmill test, or thallium myocardial scintigraphy with exercise testing and dipyridamole injection, we screened diabetic patients already enrolled in a disease management program for possible CAD. We used diagnostic coronary angiography to confirm its presence. The definition and criteria of metabolic syndrome we used were modified from those outlined by the WHO classification and criteria of NCEP-ATP III.
Results: A total of 850 T2DM patients without clinical and electrocardiographic evidence of CAD were studied. Three hundred and sixty-eight asymptomatic patients with normal resting ECG were examined by exercise ECG test or thallium scintigraphy examination. Sixty patients considered to have a strong positive test or significant thallium myocardial ischemia received a diagnostic coronary angiography. Fifty-one were found to have significant coronary artery stenosis; 9 showed no significant ischemic lesion. While gender, patients' age, known diabetes duration, serum uric acid level, smoking status, and the presence of WHO-metabolic syndrome defined hypertension and nephropathy were associated with silent CAD, logistic regression analysis found that the only predictor of silent CAD was the presence of nephropathy. The components of NCEP-ATP III-metabolic syndrome were not found to be associated with silent CAD.
Conclusions: A considerable proportion of T2DM patients have silent CAD. A diabetic patient with incipient or overt nephropathy should be examined for the presence of CAD. The definition of metabolic syndrome may be modified for early detection of CAD in patients with T2DM.
Figures
Similar articles
-
Silent myocardial ischemia in patients with diabetes: who to screen.Diabetes Care. 1999 Sep;22(9):1396-400. doi: 10.2337/diacare.22.9.1396. Diabetes Care. 1999. PMID: 10480499
-
Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus.Am J Cardiol. 2006 Jan 15;97(2):236-9. doi: 10.1016/j.amjcard.2005.07.133. Epub 2005 Dec 1. Am J Cardiol. 2006. PMID: 16442369
-
Waist circumference and metabolic syndrome: the risk for silent coronary artery disease in males.Metab Syndr Relat Disord. 2012 Jun;10(3):225-31. doi: 10.1089/met.2011.0099. Epub 2012 Feb 10. Metab Syndr Relat Disord. 2012. PMID: 22324791
-
Screening for Asymptomatic Coronary Artery Disease via Exercise Stress Testing in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2021 Nov 1;8:770648. doi: 10.3389/fcvm.2021.770648. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34790709 Free PMC article.
-
Identifying which patients with diabetes should be tested for the presence of coronary artery disease--the importance of baseline electrocardiogram and exercise testing.Can J Cardiol. 2006 Feb;22 Suppl A:9A-15A. doi: 10.1016/s0828-282x(06)70973-4. Can J Cardiol. 2006. PMID: 16485054 Review.
Cited by
-
ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.Rev Diabet Stud. 2006 Spring;3(1):21-30. doi: 10.1900/RDS.2006.3.21. Epub 2006 May 10. Rev Diabet Stud. 2006. PMID: 17491709 Free PMC article.
References
-
- Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–2038. - PubMed
-
- Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–444. - PubMed
-
- Hurst RT, Lee RW. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med. 2003;139:824–834. - PubMed
-
- Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–234. - PubMed
-
- Nesto RW, Zarich S. Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition. Circulation. 1998;97:12–15. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous